PFD report

Annette Charlton · Prevention of Future Deaths report

Pin Get email alerts Request correction

Issued 9 Jan 2015•Birmingham and Solihull

Report record

Published report and response evidence

This page connects the concerns raised in this report with statements found in recipients’ published responses. A link shows a clear evidence connection; it does not assign responsibility.

View original report
Concerns
1

Raised in this report

Recipients
6

Named on the report

Responses found
1

Of 6 recipients

Stated actions
2

Described in responses

Source document

Full report text

This is the full text from the original published report.

Open published report

Concerns and recipient responses

Select any concern, action or position to view the source wording.

Report evidence summary

Concerns raised1

  1. Almost identical medication boxes
    Part of recurring concern: Failure to ensure medication packaging is clearly distinguishable
Responses linked to these concerns

Each statement is shown once, even when linked to more than one concern.

Actions described in response An action is something a recipient says it has done, is doing, or plans to do in response to a concern raised.2

  1. Action

    Revise product artwork to minimise pharmacist dispensing errors caused by failure to verify product identity.

    Stated by Crescent Pharma LimitedStated plannedThe respondent said that this action was planned when they made their response on 9 January 2015.
  2. Action

    Meet with the MHRA to discuss packaging redesign and colour differentiation between products and strengths.

    Stated by Crescent Pharma LimitedStated plannedThe respondent said that this action was planned when they made their response on 9 January 2015.

Source evidence

How this individual concern was interpreted

PFD Monitor created a concise, searchable interpretation from the report wording shown below. Response links show a clear evidence connection; they do not assign responsibility.

PFD Monitor interpretation

Almost identical medication boxes

Wider context from the report

“(1) Manufacturers are able to produce medication in almost identical boxes which is very likely to contribute to dispensing errors and potentially patient deaths. ”

Is this part of a recurring concern?

Yes — Failure to ensure medication packaging is clearly distinguishable.

Open source report

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Revise product artwork to minimise pharmacist dispensing errors caused by failure to verify product identity.

Verbatim wording from the response

“Crescent are therefore committed to revising product artwork to help minimise pharmacist error, caused by the failure to verify product identity during dispensing.”

Source location

2015-0009-Response-by-Crescent-Pharma-Limted
Page 1 · response
Published 9 January 2015

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Meet with the MHRA to discuss packaging redesign and colour differentiation between products and strengths.

Verbatim wording from the response

“Regarding the issue of packaging similarity, Crescent has scheduled a meeting with the MHRA on the 20th January 2015 to discuss packaging redesign and use of colour to differentiate between different products and strengths, after their request to do so in May 2014.”

Source location

2015-0009-Response-by-Crescent-Pharma-Limted
Page 1 · response
Published 9 January 2015

Open published response
Back to top

Information checked against the published report and official responses · Data reviewed 7 Sep 2026 · About data quality and limitations

Official responses located
1/6

Data last updated 7 September 2026